• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ERIKA DE REYNOSA, S.A. DE C.V. LIBERTY CYCLER SET, SINGLE CONN./EXT. DL; SYSTEM, PERITONEAL, AUTOMATIC DELIVERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ERIKA DE REYNOSA, S.A. DE C.V. LIBERTY CYCLER SET, SINGLE CONN./EXT. DL; SYSTEM, PERITONEAL, AUTOMATIC DELIVERY Back to Search Results
Catalog Number 050-87216
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Myocardial Infarction (1969); Peritonitis (2252)
Event Date 01/01/2023
Event Type  Injury  
Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.Clinical investigation: it is unknown if a temporal relationship exists between ccpd therapy utilizing the liberty select cycler, liberty cycler set and the serious adverse events of an stemi (requiring hospitalization) and peritonitis, which reportedly required the patient to transition to another form of rrt.The etiology and timeline of events is unknown; therefore, causality cannot be established.However, the pdrn¿s response did not indicate a fresenius device(s) and/or product(s) malfunctioned or was deficient in any way.Myocardial infarctions are a widespread complication for patients undergoing maintenance dialysis due to their underlying and often complex cardiovascular and endocrine status.Additionally, those individuals undergoing pd therapy (manual or cycler based) are at high risk for infections of the peritoneum.Based on the information available, the liberty select cycler and liberty cycler set can be disassociated from the serious adverse events.There is no allegation or objective evidence indicating a fresenius device(s) and/or product(s) caused and/or contributed to the serious adverse events.Furthermore, there was no report a fresenius product(s) and/or device(s) failed to meet the users¿ expectations or manufacturers¿ specifications.
 
Event Description
On 08/08/2023, fresenius became aware this patient with end stage renal disease (esrd) on continuous cyclic peritoneal dialysis [cc(pd)] for renal replacement therapy (rrt) was hospitalized.During intake, the pd registered nurse (pdrn) reported the patient contracted peritonitis while hospitalized and is no longer able to perform pd therapy.A written response from the patient¿s pdrn revealed the patient was hospitalized (admission date not provided, >30-day hospitalization) due to a st elevation myocardial infarction (stemi).It was reported the patient developed peritonitis while admitted and required transition to alternate form of rrt (modality type not provided).As of 08/09/2023, the patient remained hospitalized and is recovering from the serious adverse events.Additional information (e.G., hospital records, medication records, treatment records) was requested, however the patient¿s medical record was closed.The patient was discharged from the outpatient home program after being hospitalized for >30 days.Additional information was requested however the request could not be fulfilled as the patient¿s electronic medical record was closed.
 
Event Description
On 08/08/2023, fresenius became aware this patient with end stage renal disease (esrd) on continuous cyclic peritoneal dialysis [cc(pd)] for renal replacement therapy (rrt) was hospitalized.During intake, the pd registered nurse (pdrn) reported the patient contracted peritonitis while hospitalized and is no longer able to perform pd therapy.A written response from the patient¿s pdrn revealed the patient was hospitalized (admission date not provided, >30-day hospitalization) due to a st elevation myocardial infarction (stemi).It was reported the patient developed peritonitis while admitted and required transition to alternate form of rrt (modality type not provided).As of (b)(6) 2023, the patient remained hospitalized and is recovering from the serious adverse events.Additional information (e.G., hospital records, medication records, treatment records) was requested, however the patient¿s medical record was closed.The patient was discharged from the outpatient home program after being hospitalized for >30 days.Additional information was requested however the request could not be fulfilled as the patient¿s electronic medical record was closed.
 
Manufacturer Narrative
Plant investigation: the sample was not returned to the manufacturer and the lot number was not provided.A manufacturing review was performed on the products shipped to the patient for the three (3) month time frame which immediately preceded the event occurrence date.This review included the lot numbers for all fresenius liberty cycler sets shipped to this account within the selected time frame.The entire set of lots have been sold and distributed.There were no non-conformances or abnormalities identified during the manufacturing process which could be associated with the reported event.An investigation of the device history records (dhr) was conducted and confirmed that the results of the in-progress and final quality control (qc) testing met all requirements.The product lots involved met all specifications for release.A review of the dhr did not reveal a probable cause for the customer complaint.As a physical evaluation could not be performed, a definitive conclusion regarding the reported incident could not be reached and a cause could not be confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIBERTY CYCLER SET, SINGLE CONN./EXT. DL
Type of Device
SYSTEM, PERITONEAL, AUTOMATIC DELIVERY
Manufacturer (Section D)
ERIKA DE REYNOSA, S.A. DE C.V.
mike allen #1331
parque industrial reynosa
reynosa 88780
MX  88780
Manufacturer (Section G)
ERIKA DE REYNOSA, S.A. DE C.V.
director, quality systems
900 w zaragosa drive suite d
pharr TX 78577
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key17625133
MDR Text Key321971956
Report Number0008030665-2023-00781
Device Sequence Number1
Product Code FKX
UDI-Device Identifier00840861100750
UDI-Public00840861100750
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K173718
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 10/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/25/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number050-87216
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Device AgeMO
Date Manufacturer Received09/28/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
DELFLEX PD FLUID; DELFLEX PD FLUID; LIBERTY SELECT CYCLER; LIBERTY SELECT CYCLER
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age75 YR
Patient SexFemale
Patient Weight62 KG
-
-